	US 12,239,729 B2
	TRPV3 agonists for the treatment of skin conditions
John M. Stewart, Ottawa (CA)
Assigned to Soricimed Biopharma Inc., Moncton (CA)
Filed by Soricimed Biopharma Inc., Moncton (CA)
Filed on Dec. 11, 2020, as Appl. No. 17/119,428.
Application 17/119,428 is a continuation of application No. 15/704,581, filed on Sep. 14, 2017, granted, now 10,864,152.
Application 15/704,581 is a continuation of application No. 14/428,209, abandoned, previously published as PCT/CA2013/000788, filed on Sep. 16, 2013.
Claims priority of provisional application 61/701,128, filed on Sep. 14, 2012.
Prior Publication US 2021/0137811 A1, May 13, 2021
This patent is subject to a terminal disclaimer.
Int. Cl. A61K 8/64 (2006.01); A61K 38/08 (2019.01); A61K 38/10 (2006.01); A61K 38/17 (2006.01); A61Q 19/00 (2006.01); A61Q 19/08 (2006.01); C07K 7/06 (2006.01); C07K 14/47 (2006.01)

CPC A61K 8/64 (2013.01) [A61K 38/08 (2013.01); A61K 38/10 (2013.01); A61K 38/17 (2013.01); A61K 38/1709 (2013.01); A61Q 19/00 (2013.01); A61Q 19/08 (2013.01); C07K 7/06 (2013.01); C07K 14/47 (2013.01); C07K 14/4747 (2013.01)]

4 Claims

1. A method of promoting skin repair in a subject in need thereof comprising administering a topical formulation comprising a peptide consisting of the amino acid sequence KEFLHPSKVDLPR (SEQ ID NO: 2) and an emollient to the skin of the subject.